TMED holdings

All 102 positions of T. Rowe Price Health Care ETF.

Download CSV

Positions

102

Top 10 weight

47.5%

Effective holdings

21.6

1 / sum of squared weights

In stocks

99.3%

In bonds

0.0%

Outside the US

6.7%

Asset mix

Equity99.3%
Cash0.7%

Sectors

99% of stocks classified

Health Care84.5%
Technology12.8%
Consumer Staples1.2%

Countries

United States92.5%
Denmark1.6%
Germany1.6%
Cayman Islands1.1%
Netherlands0.9%
Switzerland0.5%
Canada0.3%
Jersey0.3%
Italy0.3%
France0.1%
British Virgin Islands0.1%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	16.71%	$3.8M	3,209	US
2	UNHUNITEDHEALTH GROUP INCORPORATED (Delaware)	Equity	6.52%	$1.5M	3,614	US
3	GILDGilead Sciences Inc	Equity	4.44%	$1.0M	8,084	US
4	TMOThermo Fisher Scientific, Inc.	Equity	4.11%	$948K	1,890	US
5	DHRDanaher Corporation	Equity	2.96%	$682K	3,580	US
6	CORCencora, Inc.	Equity	2.75%	$634K	2,240	US
7	AAgilent Technologies Inc.	Equity	2.61%	$602K	4,530	US
8	ALNYAlnylam Pharmaceuticals, Inc.	Equity	2.60%	$598K	1,986	US
9	ISRGIntuitive Surgical Inc.	Equity	2.43%	$561K	1,410	US
10	PODDInsulet Corporation	Equity	2.38%	$548K	3,601	US
11	SYKStryker Corporation	Equity	2.22%	$511K	1,624	US
12	DYNDyne Therapeutics, Inc. Common Stock	Equity	2.03%	$468K	21,069	US
13	ELANElanco Animal Health Incorporated Common Stock	Equity	1.91%	$440K	17,864	US
14	PFEPfizer Inc.	Equity	1.91%	$439K	18,228	US
15	CYTKCytokinetics Inc.	Equity	1.69%	$389K	4,564	US
16	WATWaters Corp	Equity	1.68%	$388K	1,034	US
17	WSTWest Pharmaceutical Services, Inc.	Equity	1.65%	$381K	1,060	US
18	ASNDAscendis Pharma A/S Ordinary Share	Equity	1.60%	$369K	1,382	DK
19	BIIBBiogen Inc. Common Stock	Equity	1.55%	$357K	1,654	US
20	MCKMcKesson Corporation	Equity	1.46%	$335K	444	US
21	DXCMDexCom, Inc.	Equity	1.46%	$335K	4,976	US
22	IMNMImmunome, Inc.	Equity	1.38%	$318K	15,009	US
23	BNTXBioNTech SE American Depositary Share	Equity	1.29%	$297K	3,188	DE
24	HUMHumana Inc.	Equity	1.24%	$286K	721	US
25	DNLIDenali Therapeutics Inc. Common Stock	Equity	1.22%	$282K	10,962	US
26	CVSCVS HEALTH CORPORATION	Equity	1.22%	$281K	2,717	US
27	IDXXIdexx Laboratories Inc	Equity	1.18%	$271K	515	US
28	PCVXVaxcyte, Inc. Common Stock	Equity	1.18%	$271K	4,655	US
29	MTDMettler-Toledo International	Equity	0.97%	$222K	174	US
30	HCAHCA Healthcare, Inc.	Equity	0.95%	$219K	562	US
31	IMTXImmatics N.V. Ordinary Shares	Equity	0.87%	$200K	19,722	NL
32	RGENRepligen Corp	Equity	0.85%	$195K	1,430	US
33	ELVElevance Health, Inc.	Equity	0.77%	$176K	456	US
34	STTKShattuck Labs, Inc. Common Stock	Equity	0.76%	$176K	25,348	US
35	APGEApogee Therapeutics, Inc. Common Stock	Equity	0.75%	$174K	1,309	US
36	STATE STREET INS US GO MM FD-IS	Cash	0.73%	$169K	169,172	US
37	BDXBecton, Dickinson and Co.	Equity	0.72%	$166K	1,098	US
38	MLTXMoonLake Immunotherapeutics Class A Ordinary Shares	Equity	0.66%	$152K	7,823	KY
39	COOThe Cooper Companies, Inc. Common Stock	Equity	0.65%	$150K	2,088	US
40	CABACabaletta Bio, Inc. Common Stock	Equity	0.62%	$142K	45,659	US
41	CGONCG Oncology, Inc. Common stock	Equity	0.62%	$142K	1,996	US
42	THCTenet Healthcare Corporation New	Equity	0.56%	$130K	693	US
43	BCAXBicara Therapeutics Inc. Common Stock	Equity	0.53%	$122K	4,103	US
44	ALHCAlignment Healthcare, Inc. Common Stock	Equity	0.50%	$115K	4,840	US
45	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	0.47%	$109K	6,068	US
46	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.47%	$109K	949	US
47	RVTYRevvity, Inc.	Equity	0.45%	$103K	926	US
48	ADPTAdaptive Biotechnologies Corporation Common Stock	Equity	0.42%	$96K	4,479	US
49	MOHMolina Healthcare, Inc.	Equity	0.41%	$95K	416	US
50	ONCBeOne Medicines Ltd. American Depositary Shares	Equity	0.40%	$92K	322	CH
51	MPLTMapLight Therapeutics, Inc. Common Stock	Equity	0.40%	$91K	2,543	US
52	AKESO INC	Equity	0.39%	$90K	8,000	KY
53	KODKodiak Sciences Inc Common Stock	Equity	0.36%	$84K	2,147	US
54	WGSGeneDx Holdings Corp. Class A Common Stock	Equity	0.36%	$82K	1,200	US
55	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	0.35%	$80K	816	US
56	AVTXAvalo Therapeutics, Inc. Common Stock	Equity	0.34%	$79K	4,287	US
57	INCYIncyte Genomics Inc	Equity	0.33%	$76K	669	US
58	FDMT4D Molecular Therapeutics, Inc. Common Stock	Equity	0.32%	$74K	5,545	US
59	XENEXenon Pharmaceuticals Inc	Equity	0.32%	$73K	1,216	CA
60	NVCRNovoCure Limited Ordinary Shares	Equity	0.31%	$72K	4,764	JE
61	EIKNEikon Therapeutics, Inc. Common Stock	Equity	0.31%	$72K	5,522	US
62	ORKAOruka Therapeutics, Inc. Common Stock	Equity	0.31%	$71K	746	US
63	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.31%	$71K	2,167	US
64	OKUROnKure Therapeutics, Inc. Class A Common Stock	Equity	0.30%	$70K	15,335	US
65	STVNStevanato Group S.p.A.	Equity	0.30%	$70K	3,869	IT
66	SARTORIUS AG	Equity	0.30%	$69K	320	DE
67	CAICaris Life Sciences, Inc. Common Stock	Equity	0.29%	$66K	3,694	US
68	KARDKardigan, Inc. Common Stock	Equity	0.28%	$64K	2,695	US
69	CRNXCrinetics Pharmaceuticals, Inc.	Equity	0.26%	$60K	1,596	US
70	GRALGRAIL, Inc. Common Stock	Equity	0.26%	$59K	868	US
71	RCUSArcus Biosciences, Inc.	Equity	0.25%	$58K	1,868	US
72	MAZEMaze Therapeutics, Inc. Common Stock	Equity	0.21%	$49K	1,656	US
73	AKTSAktis Oncology, Inc. Common stock	Equity	0.21%	$49K	1,517	US
74	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.21%	$48K	23,151	US
75	ORICOric Pharmaceuticals, Inc. Common Stock	Equity	0.21%	$47K	4,380	US
76	RAPPRapport Therapeutics, Inc. Common Stock	Equity	0.20%	$47K	1,127	US
77	AMLXAmylyx Pharmaceuticals, Inc. Common Stock	Equity	0.20%	$47K	2,611	US
78	SYRESpyre Therapeutics, Inc. Common Stock	Equity	0.20%	$47K	525	US
79	DMRADamora Therapeutics, Inc. Ordinary Shares	Equity	0.20%	$47K	1,788	US
80	ELVNEnliven Therapeutics, Inc. Common Stock	Equity	0.20%	$45K	891	US
81	PRCTPROCEPT BioRobotics Corporation Common Stock	Equity	0.19%	$44K	1,951	US
82	IRONDisc Medicine, Inc. Common Stock	Equity	0.19%	$44K	600	US
83	AVLNAvalyn Pharma Inc. Common Stock	Equity	0.18%	$41K	1,244	US
84	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.18%	$40K	509	US
85	SDGRSchrodinger, Inc. Common Stock	Equity	0.16%	$36K	2,236	US
86	BDTXBlack Diamond Therapeutics, Inc. Common Stock	Equity	0.12%	$28K	15,259	US
87	ABVXAbivax SA American Depositary Shares	Equity	0.12%	$28K	209	FR
88	ERASErasca, Inc. Common Stock	Equity	0.12%	$27K	1,460	US
89	PSNLPersonalis, Inc. Common Stock	Equity	0.12%	$27K	1,990	US
90	KPTIKaryopharm Therapeutics Inc.	Equity	0.10%	$24K	2,470	US
91	PRMEPrime Medicine, Inc. Common Stock	Equity	0.10%	$23K	6,152	US
92	IMVTImmunovant, Inc. Common Stock	Equity	0.10%	$22K	580	US
93	BHVNBiohaven Ltd.	Equity	0.09%	$22K	1,458	VG
94	CRSPCRISPR Therapeutics AG	Equity	0.09%	$21K	381	CH
95	N/A	Equity	0.08%	$18K	3,159	US
96	ANNXAnnexon, Inc. Common Stock	Equity	0.05%	$12K	2,087	US
97	N/A	Equity	0.01%	$2K	5,370	US
98	N/A	Equity	0.00%	$0	2,477	US
99	CNTACentessa Pharmaceuticals plc American Depositary Shares	Equity	0.00%	$0	1,490	GB
100	N/A	Equity	0.00%	$0	499	US
101	APPLIED THERAPEUTICS INC CVR	Equity	0.00%	$0	153,622	US
102	PFEPfizer Inc.	Equity	0.00%	$0	1,892	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	ABTABBOTT LABORATORIES	3.91%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	MDTMEDTRONIC PLC	2.24%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ISRGINTUITIVE SURGICAL INC	0.30%	2.43%	+945.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PFEPFIZER INC	0.00%	1.91%	+857.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CORCENCORA INC	1.06%	2.75%	+225.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PODDINSULET CORP	0.83%	2.38%	+345.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	BSXBOSTON SCIENTIFIC CORP	1.47%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	MCKMCKESSON CORP	—	1.46%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	APLSAPELLIS PHARMACEUTICALS INC	1.02%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	REGNREGENERON PHARMACEUTICALS	1.02%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	BDXBECTON DICKINSON AND CO	1.71%	0.72%	−50.4%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	HCAHCA HEALTHCARE INC	—	0.95%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AAGILENT TECHNOLOGIES INC	1.69%	2.61%	+50.3%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	ELVELEVANCE HEALTH INC	—	0.77%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DNLIDENALI THERAPEUTICS INC	0.48%	1.22%	+112.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	BMYBRISTOL-MYERS SQUIBB CO	0.73%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	AGIOAGIOS PHARMACEUTICALS INC	0.65%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	NVONOVO-NORDISK A/S-SPONS ADR	0.58%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	THCTENET HEALTHCARE CORP	—	0.56%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ALGNALIGN TECHNOLOGY INC	0.54%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ALNYALNYLAM PHARMACEUTICALS INC	2.06%	2.60%	+56.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ALKSALKERMES PLC	0.53%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	ALHCALIGNMENT HEALTHCARE INC	—	0.50%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	NTRANATERA INC	0.50%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BNTXBIONTECH SE-ADR	0.80%	1.29%	+73.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DXCMDEXCOM INC	1.01%	1.46%	+52.1%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	RVTYREVVITY INC	—	0.45%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	IDXXIDEXX LABORATORIES INC	0.74%	1.18%	+92.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	GHGUARDANT HEALTH INC	0.42%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	XENEXENON PHARMACEUTICALS INC	0.73%	0.32%	−52.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ADPTADAPTIVE BIOTECHNOLOGIES	0.83%	0.42%	−63.2%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	ONCBEONE MEDICINES LTD-ADR	—	0.40%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	AKESO INC	—	0.39%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ERASERASCA INC	0.51%	0.12%	−77.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	CNTACENTESSA PHARMACEUTICALS-ADR CVR	0.39%	0.00%	−25.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	EWEDWARDS LIFESCIENCES CORP	0.38%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	IMCRIMMUNOCORE HOLDINGS PLC-ADR	0.37%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ICLRICON PLC	0.33%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ELANELANCO ANIMAL HEALTH INC	1.59%	1.91%	+32.2%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	FDMT4D MOLECULAR THERAPEUTICS IN	—	0.32%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	INCYINCYTE CORP	0.65%	0.33%	−52.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	RAPPRAPPORT THERAPEUTICS INC	0.52%	0.20%	−67.0%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	ORKAORUKA THERAPEUTICS INC	—	0.31%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	OKURONKURE THERAPEUTICS INC	—	0.30%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	MOHMOLINA HEALTHCARE INC	0.71%	0.41%	−61.8%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	SARTORIUS AG	—	0.30%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BIIBBIOGEN INC	1.26%	1.55%	+18.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GILDGILEAD SCIENCES INC	4.14%	4.43%	+33.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	TVTXTRAVERE THERAPEUTICS INC	0.29%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	BCAXBICARA THERAPEUTICS INC	0.82%	0.53%	−50.9%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	KARDKARDIGAN INC	—	0.28%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	SRPTSAREPTA THERAPEUTICS INC	0.73%	0.47%	−11.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	RLAYRELAY THERAPEUTICS INC	0.26%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	YPSOMED HOLDING AG-REG	0.25%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	MLTXMOONLAKE IMMUNOTHERAPEUTICS	0.89%	0.66%	−20.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DHRDANAHER CORP	2.73%	2.96%	+21.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	IMNMIMMUNOME INC	1.15%	1.38%	+39.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	OSCROSCAR HEALTH INC - CLASS A	0.23%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	PRMEPRIME MEDICINE INC	0.32%	0.10%	−66.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SYKSTRYKER CORP	2.00%	2.22%	+30.7%	Mar 31, 2026 → Jun 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.